EPISODE · May 20, 2026 · 47 MIN
The Truth About Treatment-Resistant Depression with Jasmine Blocker
from Conversations with Cam · host Cameron Oaks Rogers
In this episode sponsored by Johnson & Johnson, I sit down with world champion sprinter and mental health advocate Jasmine Blocker. Jasmine talks about how sports have shaped her life and her decision to speak openly about mental health. She also shares her journey with major depressive disorder (MDD)—cycling through adequate trials of multiple depression medications without finding symptom relief—before being diagnosed with treatment-resistant depression (TRD).Jasmine discusses what it meant to finally receive a TRD diagnosis, actively participating in treatment decisions, and how SPRAVATO® (esketamine) CIII nasal spray helped relieve her depressive symptoms. Every patient’s experience is different, so if you or an adult you know has been experiencing TRD, talk to a healthcare provider about SPRAVATO® and whether it may be the right fit. Visit SPRAVATO.com to learn more, including information on serious side effects such as sedation, dissociation, respiratory depression, and the risk of abuse and misuse. Please read full Prescribing Information, including Boxed WARNINGS: https://jmc.link/3RMl24d & Med Guide: https://jmc.link/3aWgBTY INDICATION SPRAVATO® (esketamine) CIII nasal spray is a prescription medicine indicated for adults with TRD, used alone or in conjunction with an oral antidepressant.SPRAVATO® is not for use as a medicine to prevent or relieve pain (anesthetic). It is not known if SPRAVATO® is safe or effective as an anesthetic medicine or for use in preventing suicide or reducing suicidal thoughts or actions. It is not for use in place of hospitalization. It is not known if SPRAVATO® is safe and effective in children. SPRAVATO® is only available through a restricted distribution program called the SPRAVATO® Risk Evaluation and Mitigation Strategy (REMS) program. This means you are under the direct supervision of a healthcare provider while you self-administer the nasal spray and are monitored for at least two hours afterwards to keep track of any serious side effects.Call your doctor for medical advice about side effects. You may report side effects to Johnson & Johnson at 1-800-526-7736, or to the FDA at 1-800-FDA-1088.Remember, this content is not intended to be a substitute for medical advice, diagnosis or treatment. Please talk to your healthcare provider if you have any questions about your health, including treatment options. They are always your best resource for medical information.Follow Jasmine:Instagram: @jas_blockerTikTok: @jas_blockerFollow me:Instagram: @cameronoaksrogersSubstack: Fill Your CupWebsite: cameronoaksrogers.comTikTok: @cameronoaksrogersYoutube: Cameron Rogers
What this episode covers
In this episode sponsored by Johnson & Johnson, I sit down with world champion sprinter and mental health advocate Jasmine Blocker. Jasmine talks about how sports have shaped her life and her decision to speak openly about mental health. She also shares her journey with major depressive disorder (MDD)—cycling through adequate trials of multiple depression medications without finding symptom relief—before being diagnosed with treatment-resistant depression (TRD).Jasmine discusses what it meant to finally receive a TRD diagnosis, actively participating in treatment decisions, and how SPRAVATO® (esketamine) CIII nasal spray helped relieve her depressive symptoms. Every patient’s experience is different, so if you or an adult you know has been experiencing TRD, talk to a healthcare provider about SPRAVATO® and whether it may be the right fit. Visit SPRAVATO.com to learn more, including information on serious side effects such as sedation, dissociation, respiratory depression, and the risk of abuse and misuse. Please read full Prescribing Information, including Boxed WARNINGS: https://jmc.link/3RMl24d & Med Guide: https://jmc.link/3aWgBTY INDICATION SPRAVATO® (esketamine) CIII nasal spray is a prescription medicine indicated for adults with TRD, used alone or in conjunction with an oral antidepressant.SPRAVATO® is not for use as a medicine to prevent or relieve pain (anesthetic). It is not known if SPRAVATO® is safe or effective as an anesthetic medicine or for use in preventing suicide or reducing suicidal thoughts or actions. It is not for use in place of hospitalization. It is not known if SPRAVATO® is safe and effective in children. SPRAVATO® is only available through a restricted distribution program called the SPRAVATO® Risk Evaluation and Mitigation Strategy (REMS) program. This means you are under the direct supervision of a healthcare provider while you self-administer the nasal spray and are monitored for at least two hours afterwards to keep track of any serious side effects.Call your doctor for medical advice about side effects. You may report side effects to Johnson & Johnson at 1-800-526-7736, or to the FDA at 1-800-FDA-1088.Remember, this content is not intended to be a substitute for medical advice, diagnosis or treatment. Please talk to your healthcare provider if you have any questions about your health, including treatment options. They are always your best resource for medical information.Follow Jasmine:Instagram: @jas_blockerTikTok: @jas_blockerFollow me:Instagram: @cameronoaksrogersSubstack: Fill Your CupWebsite: cameronoaksrogers.comTikTok: @cameronoaksrogersYoutube: Cameron Rogers
NOW PLAYING
The Truth About Treatment-Resistant Depression with Jasmine Blocker
No transcript for this episode yet
Similar Episodes
No similar episodes found.